Publication | Closed Access

HITM-SIR: phase Ib trial of intraarterial chimeric antigen receptor T-cell therapy and selective internal radiation therapy for CEA+ liver metastases

Radiation MedicineHepatologyRadiation TherapyMedicineImmunologyPhase Ib TrialLiver CancerCea+ Liver MetastasesImmunotherapyOncologyRadiation Oncology